Global Isothermal Nucleic Acid Amplification Technology/INAAT Market – Industry Trends and Forecast to 2030

Isothermal Nucleic Acid Amplification Technology/INAAT Market Analysis and Size

INAAT applications for diagnosing infectious diseases held the lion's share with 34.84% of the market. The important drivers that are expected to drive the segment growth include the recent development of particular INAAT kits and the rising prevalence of HIV, hepatitis A and B and sexually transmitted illnesses. The technology is becoming much more in demand as a molecular testing method due to the increased incidence of infectious diseases. The most common infectious diseases that contribute to death include tuberculosis, hepatitis, and influenza, especially in underdeveloped nations. The popularity of isothermal nucleic acid amplification technology (INAAT) solutions is anticipated to increase in response to the desire for quick, simple and disease-specific testing choices.

Data Bridge Market Research analyses that the isothermal nucleic acid amplification technology/INAAT market which is USD 537.32 billion in 2022, is expected to reach USD 1438.58 billion by 2030, at a CAGR of 13.1% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Isothermal Nucleic Acid Amplification Technology/INAAT Market Scope and Segmentation  

Market Definition

The isothermal nucleic acid amplification technology (INAAT) is used to detect and identify nucleic acids in molecular biology and recombinant DNA technologies. It is frequently used to amplify nucleic acids at a constant temperature, removing the need for thermocycler equipment.

Isothermal Nucleic Acid Amplification Technology/INAAT Market Dynamics

Drivers

• Increase in demand for quick and reliable test alternatives

COVID-19 has positively impacted the market growth due to the increase in demand for quick and reliable test alternatives for the identification of the SARS-CoV-2 virus. A number of significant businesses has created new COVID-19 testing products based on INAAT and they have received FDA approval for emergency use. Some commercially available products in this field are the Lucira CHECK-IT COVID-19 test kit and the Procleix SARS-CoV-2 assay from Grifols Diagnostic Solutions Inc. The COVID-19 pandemic-driven strategic actions mentioned above are probably going to give the market a big boost in the near future.

• New applications for INAAT products

New applications for INAAT products are emerging as a result of the quick development of existing amplification technologies as well as the introduction of novel technologies such as Single Primer Isothermal Amplification (SPIA), Loop-Mediated Isothermal Amplification (LAMP), Recombinase Polymerase Amplification (RPA), and Strand Displacement Amplification (SDA). For instance, a study that used the LAMP technology that was published in the Analyst Journal in June 2022 showed how a smartphone-integrated equipment could quickly test for the Zika virus in a single blood drop. Such advances are probably going to increase the technique's market penetration in the near future.

Opportunities

• Rising prevalence of infectious disorders

Isothermal nucleic acid amplification technology (INAAT) is needed to diagnosis the rising prevalence of infectious disorders such Haemophilus influenzae, Streptococcus pneumoniae (respiratory tract infections), Neisseria gonorrhoeae, Chlamydia trachomatis (genital infections) and TB. For instance, the World Health Organization estimates that 17 million people worldwide die from infectious diseases each year. Another data from the Centers for Disease Control reveals a three-fold increase in the number of diseases spread by ticks, fleas, and mosquitoes, including West Nile, Zika, malaria, and Lyme disease. Similarly, according to a poll conducted by NCBI, around 157 million people in the United States, or 50% of the population, had at least one chronic condition in 2020. The demand for diagnosis using isothermal nucleic acids is driven by an increase in infectious or chronic diseases.

Restraints/Challenges

• Side effects associated with isothermal nucleic acid amplification technology

The requirement of instrumentation capable of thermal cycling and temperature control hampers the use of point-of-care applications for amplification techniques such as PCR. The regulatory environment guiding the creation of INAAT-based diagnostics is a significant issue restricting industry expansion. The strict regulations used by regulatory organizations including the U.S. FDA, EMEA, and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for monitoring the manufacturing processes of INAAT production add to the difficulties involved in INAAT manufacture.

This isothermal nucleic acid amplification technology/INAAT market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the isothermal nucleic acid amplification technology/INAAT market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Isothermal Nucleic Acid Amplification Technology/INAAT Market

The market's growth is anticipated to be significantly impacted by COVID-19. Isothermal techniques were used as a foundational technology for the diagnosis of SARS-CoV-2 RNA in homes and clinical testing facilities during the COVID-19 pandemic. Additionally, in March 2020, Abbott was granted permission by the US Food and Drug Administration to employ ID NOW COVID-19, an instrument-based, isothermal, fast approach for the qualitative discovery of disease, in emergency situations. Thus, it is anticipated that increased usage during pandemics and product approvals and launches will accelerate the market's growth throughout the forecast period.

Recent Developments

• In 2022, The exclusive partnership between LGC Clinical Diagnostics and Stanford Medicine's Department of Obstetrics and Gynecology and Metabolic Health Center, which supports international genetic and metabolic diagnostic testing, was extended, according to an announcement.
• In 2022, Lyo-Ready Direct DNA LAMP Saliva Mix and Lyo-Ready Direct RNA/DNA LAMP Saliva Mix are two brand-new, cutting-edge isothermal amplification solutions that Meridian Bioscience introduced. These are employed in point-of-care diagnostic tests for the direct detection of DNA and RNA.

Global Isothermal Nucleic Acid Amplification Technology/INAAT Market Scope

The isothermal nucleic acid amplification technology/INAAT market is segmented on the basis of product, type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Assays
• Kits and Reagents
• Systems

 Type

• Transcription-Mediated Amplification
• Loop-Mediated Isothermal Amplification
• Strand Displacement Amplification
• Helicase-Dependent Amplification
• Nucleic Acid Sequence-Based Amplification
• Other Technologies

 Application

• Infectious Disease Diagnosis
• Hepatitis
• Ct/Ng
• HIV
• Influenza
• Other infectious diseases
• Blood Screening
• Other Applications

End User

• Hospitals
• Reference Laboratories
• Academic and Research Institutes
• Other End Users

Isothermal Nucleic Acid Amplification Technology/INAAT Market Regional Analysis/Insights

The isothermal nucleic acid amplification technology/INAAT market is analyzed and market size insights and trends are provided by country, product, type, application and end user as referenced above.

The countries covered in the isothermal nucleic acid amplification technology/INAAT market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the isothermal nucleic acid amplification technology/INAAT market due to the widespread use of an upgraded healthcare system and the adoption of cutting-edge technologies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to increase in the average person's disposable income and the expansion of a modernized healthcare infrastructure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The isothermal nucleic acid amplification technology/INAAT market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for isothermal nucleic acid amplification technology/INAAT market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the isothermal nucleic acid amplification technology/INAAT market. The data is available for historic period 2011-2021.

Competitive Landscape and Isothermal Nucleic Acid Amplification Technology/INAAT Market Share Analysis

The isothermal nucleic acid amplification technology/INAAT market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to isothermal nucleic acid amplification technology/INAAT market.

Some of the major players operating in the isothermal nucleic acid amplification technology/INAAT market are:

• Siemens (Germany)
• Hologic, Inc. (U.S.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Abbott (U.S.)
• BD (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Thermo Fisher Scientific (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• NeuroLogica Corp. (U.S.)
• Shimadzu Medical (India) pvt. Ltd. (Japan)
• General Electric (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• Sysmex India Pvt. Ltd. (Japan)
• Hitachi, Ltd. (Japan)
• Canon Inc. (Japan)
• FUJIFILM Holdings Corporation (U.K.)

SKU-52422